Delivery Order SPE2DE24DA010-SPE2D626F5Y40
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $28,350 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment is scheduled for completion by January 20, 2026, and will be performed in Santa Clara, California. The delivery order carries no set-aside designation and was awarded through full and open competition, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $41,268 under the Defense Logistics Agency's Medical Supply Chain program, awarded on December 5, 2025, with performance completion targeted for December 10, 2025. This fixed-price contract with economic price adjustment mechanism was awarded through full and open competition with no set-aside designation to Abbott Vascular at its Santa Clara, California location. The Defense Logistics Agency...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a $28,350 fixed-price delivery order (4570509248) from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 20, 2026. This delivery order was awarded without a set-aside designation through full and open competition and will be performed in Santa Clara, California. The award represents a task order under Abbott's existing $117.1 million Indefinite Delivery Contract...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 17, 2025. This delivery order, issued without a small business set-aside designation, represents a task order against Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive cardiovascular...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $25,875.85 fixed-price delivery order (Contract No. 4570444146, GALLANT) by the Defense Logistics Agency Medical Supply Chain on January 8, 2026, with performance completion targeted for January 13, 2026. The award was made without set-aside designation through full and open competition and will be performed in Santa Clara, California. This delivery order represents a discrete procurement action under Abbott's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on January 20, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by January 23, 2026, and will be performed at Abbott's location in Santa Clara, California. This award represents a task order issued under the Defense Logistics Agency's...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F5Y40Delivery Order
The Defense Logistics Agency Medical Supply Chain issued an $11,750 fixed-price delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 25, 2026, with a completion date of March 30, 2026. Place of performance is Santa Clara, California. Abbott Vascular is a strategic federal supplier of advanced cardiovascular medical technologies, including stents, pacemakers, heart valves, implantable cardiac monitors, left ventricular assist devices, and transcatheter valve repair systems. The company holds a major $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive cardiovascular procedural packages covering devices, instrumentation, accessories, and related medical technologies, which has generated numerous task orders throughout 2024 and 2025. Abbott has secured multiple additional IDCs with Veterans Integrated Service Networks for consignment inventory of transcatheter prosthetic surgical heart valves and specialized cardiac implants through 2029 and 2030, demonstrating sustained federal healthcare procurement relationships. All Abbott federal contract awards carry no set-aside designations, reflecting the company's competitive positioning among qualified federal contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 3/24/26 |